alanine has been researched along with Triple Negative Breast Neoplasms in 2 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We here investigated the activity of E-3810 combined with different cytotoxic agents in a MDA-MB-231 triple-negative breast cancer xenograft model." | 1.39 | The tyrosine kinase inhibitor E-3810 combined with paclitaxel inhibits the growth of advanced-stage triple-negative breast cancer xenografts. ( Bello, E; Berndt, A; Camboni, G; Cavalletti, E; Colella, G; D'Incalci, M; Damia, G; Forestieri, D; Giavazzi, R; Licandro, SA; Richter, P; Taraboletti, G; Zucchetti, M, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Žukauskas, M | 1 |
| Grybaitė, B | 1 |
| Jonutė, P | 1 |
| Vaickelionienė, R | 1 |
| Gibieža, P | 1 |
| Vaickelionis, G | 1 |
| Dragūnaitė, B | 1 |
| Anusevičius, K | 1 |
| Mickevičius, V | 1 |
| Petrikaitė, V | 1 |
| Bello, E | 1 |
| Taraboletti, G | 1 |
| Colella, G | 1 |
| Zucchetti, M | 1 |
| Forestieri, D | 1 |
| Licandro, SA | 1 |
| Berndt, A | 1 |
| Richter, P | 1 |
| D'Incalci, M | 1 |
| Cavalletti, E | 1 |
| Giavazzi, R | 1 |
| Camboni, G | 1 |
| Damia, G | 1 |
2 other studies available for alanine and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Evaluation of N-aryl-β-alanine derivatives as anticancer agents in triple-negative breast cancer and glioblastoma in vitro models.
Topics: Alanine; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response R | 2021 |
The tyrosine kinase inhibitor E-3810 combined with paclitaxel inhibits the growth of advanced-stage triple-negative breast cancer xenografts.
Topics: Alanine; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Drug Synergism; | 2013 |